Asenapine Maleate

FDA Drug Profile — SAPHRIS

Drug Details

Generic Name
Asenapine Maleate
Brand Names
SAPHRIS
Application Number
NDA022117
Sponsor
Olon SpA
NDC Codes
16
Dosage Forms
POWDER, TABLET
Routes
SUBLINGUAL
Active Ingredients
ASENAPINE MALEATE

Indications and Usage

1 INDICATIONS AND USAGE Asenapine sublingual tablets are indicated for: Schizophrenia in adults [see Clinical Studies (14.1) ] Bipolar I disorder [see Clinical Studies (14.2) ] Acute monotherapy of manic or mixed episodes, in adults and pediatric patients 10 to 17 years of age Adjunctive treatment to lithium or valproate in adults Maintenance monotherapy treatment in adults Asenapine sublingual tablets are an atypical antipsychotic indicated for ( 1 ): Schizophrenia in adults Bipolar I disorder Acute monotherapy treatment of manic or mixed episodes, in adults and pediatric patients 10 to 17 years of age Adjunctive treatment to lithium or valproate in adults Maintenance monotherapy treatment in adults